BioMS Medical Corp (“BioMS” or the “Corporation”) (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the second quarter ended June 30, 2006.
BioMS Medical Corp (“BioMS” or the “Corporation”) (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the second quarter ended June 30, 2006.
